Resultados de la búsqueda 201-210 of 10759 for monoclonal antibody

  1. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...

  3. Síntomas y causas - Mayo Clinic

    Descripción general. Diffuse large B-cell lymphoma (DLBCL) is a type of lymphoma. Lymphoma is cancer that affects the lymphatic system.

  4. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  6. B-cell lymphoma - Diagnósticos y tratamientos - Mayo Clinic

    Diagnosis of B-cell lymphomas often begins with a physical exam that checks for swollen lymph nodes in the neck, underarms and groin and an enlarged spleen or ...

  7. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...